Leap Therapeutics surges 170% after $50M Zcash buy with Winklevoss backing
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token.
The biotech firm is shifting to a crypto-focused strategy, backed by Winklevoss Capital, and investing $50 million in the Zcash protocol's native token.
Original source
Read on CointelegraphRelated market context
Strategy’s Michael Saylor targets $15-30T for Bitcoin-backed credit instruments
Saylor's Bitcoin-backed credit strategy could reshape global finance, integrating crypto into mainstream credit markets and alteri...
Crypto Firms Scrap Tokenized SpaceX Share Offerings as SPCX Surges After IPO
Participants were refunded and did not receive shares in the record-breaking SpaceX IPO from Elon Musk's rocket company.
Strategy Stock MSTR Offers Bitcoin Exposure At 18% Discount
Bitcoin Magazine Strategy Stock MSTR Offers Bitcoin Exposure At 18% Discount I’ve been vocal about accumulating Bitcoin aggressive...
Michael Saylor defends Strategy’s Bitcoin reporting metrics against Jack Mallers
The debate highlights the need for transparent metrics in valuing Bitcoin-focused firms, impacting investor trust and market strat...
Strategy’s Michael Saylor commits to raising capital with STRC above par
Saylor's strategy could stabilize STRC's market value, ensuring consistent capital flow for Bitcoin investments, impacting crypto...
Tom Shaughnessy: Investment focus is shifting from crypto to AI, retail investors prefer AGI stocks over Bitcoin, and upcoming AI IPOs may face financial disclosure challenges | Unchained
Shifting investment focus from crypto to AI reveals changing market dynamics and potential growth challenges. The post Tom Shaughn...